paclitaxel/carboplatin

DRUG7 trials

Conditions

CarcinomaEndometrial CarcinomaHead and Neck Squamous Cell CarcinomaNSCLCNeoplasms, Unknown PrimaryNon Small Cell Lung CancerNon-small Cell Lung CancerUterine Carcinoma

Phase 1

Uterine Serous Carcinoma and Adjuvant Combined Intraperitoneal Chemotherapy and Radiation

WithdrawnNCT04030000

Northwell HealthUterine Carcinoma

Start: 2020-05-20End: 2023-01-30Updated: 2023-03-17

Phase 2

Paclitaxel/Carboplatin With or Without Cetuximab in CUP

NCT00894569

Heidelberg UniversityCarcinoma, Neoplasms, Unknown Primary

Start: 2009-07-31End: 2011-08-31Target: 150Updated: 2009-05-14

Concurrent Endostar, Paclitaxel/Carboplatin and Radiotherapy for Locally Advanced Non-small Cell Lung (RT0902)

NCT01158144

Zhejiang Cancer HospitalNon-small Cell Lung Cancer

Start: 2009-10-31End: 2013-12-31Target: 134Updated: 2010-07-08

Paclitaxel/Carboplatin (PC) Followed by Gefitinib Versus PC in Advanced Non-small Cell Lung Cancer

CompletedNCT01196234

Asan Medical CenterNon Small Cell Lung Cancer

Start: 2009-12-31End: 2012-12-31Updated: 2013-01-29

Trial of Neoadjuvant Therapy With Paclitaxel and Carboplatin in Operable Locally Advanced Head and Neck Cancer Patients

CompletedNCT05294900

Yonsei UniversityHead and Neck Squamous Cell Carcinoma

Start: 2023-05-26End: 2025-10-22Updated: 2026-05-26

Phase 3

CT-2103/Carboplatin vs Paclitaxel/Carboplatin for NSCLC in Women With Estradiol > 25 pg/mL

WithdrawnNCT00576225

CTI BioPharmaNSCLC

Start: 2007-09-30End: 2010-04-05Updated: 2020-10-19

Unknown Phase

Combination Chemotherapy of Paclitaxel and Carboplatin With or Without Anthracycline as Aneo Adjuvant Treatment in Advanced Endometrial Carcinoma

CompletedNCT06102252

Sohag UniversityEndometrial Carcinoma

Start: 2024-08-15End: 2025-12-01Updated: 2026-05-22

Related Papers

Adding cetuximab to paclitaxel and carboplatin for first-line treatment of carcinoma of unknown primary (CUP): results of the Phase 2 AIO trial PACET-CUP.

2020-11-254 citations

Paclitaxel/carboplatin with or without cetuximab for treatment of carcinoma with unknown primary (PACET-CUP): Results of a multi-center randomized phase II AIO trial.

Journal of Clinical Oncology2019-05-202 citations

Randomized phase II study of paclitaxel/carboplatin intercalated with gefitinib compared to paclitaxel/carboplatin alone for chemotherapy-naïve non-small cell lung cancer in a clinically selected population excluding patients with non-smoking adenocarcinoma or mutated EGFR.

2015-10-2216 citations